Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

Ventana and Bayer Extend Collaboration
Thursday, March 13, 2014
The multi-year agreement to develop companion diagnostics focuses on immunohistochemistry.

Exosome Diagnostics Raises $27 Million in Series B Financing
Wednesday, March 12, 2014
Proceeds will be used to advance development of the company's proprietary platform technology and commercial programs.

CE-microArray Project to Develop Sepsis Test
Wednesday, March 12, 2014
£1.3M project to provide early detection of an illness which kills millions of people each year.

Enigma Dx Secures Additional Funding for Multi-Drug Resistant TB Assay
Wednesday, March 12, 2014
This grant will support further development of Enigma's test for multi-drug resistant tuberculosis on its CE Marked Enigma® Mini Laboratory system.

Grant Instruments wins VWR UK Supplier of the Year Award 2013
Monday, March 10, 2014
Award recognizes suppliers who deliver significant sales growth, outstanding customer and technical service, product training and sales support to VWR’s UK organization.

Vermillion Reports Fourth Quarter and Full Year 2013 Results
Saturday, March 08, 2014
Company will next pursue a national price for its OVA1 test in 2014.

Vermillion to Present at the 26th Annual ROTH Conference
Thursday, March 06, 2014
Company to present at the conference on March 11, 2014.

Immunexpress Closes $6M Financing Round led by Debiopharm
Thursday, March 06, 2014
Funding to advance development of the Immunexpress SeptiCyte® technology.

Insight Genetics and Vanderbilt-Ingram Cancer Center Partner
Wednesday, March 05, 2014
Research collaboration includes exclusive licensing agreement to commercialize a new genetic test that will improve treatment selection for breast cancer patients with poor prognosis.

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 1402
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to